• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因通过提高药物外排和生物膜形成来增强对唑类药物的耐药性。

Gene Enhances Drug Resistance to Azoles by Improving Drug Efflux and Biofilm Formation.

机构信息

Key Laboratory of Animal Disease and Human Health of Sichuan Province, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China.

College of Life Sciences, Sichuan Agricultural University, Chengdu 611130, China.

出版信息

Int J Mol Sci. 2023 May 16;24(10):8855. doi: 10.3390/ijms24108855.

DOI:10.3390/ijms24108855
PMID:37240199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10219205/
Abstract

is an opportunistic pathogen that can cause severe or even fatal infections in patients with low immune function. plays different roles in different fungi and is also related to fungal drug resistance. However, the mechanism underlying its drug resistance to azoles has not yet been reported in . Therefore, we investigated the drug resistance of () by constructing overexpressing mutant strains (TaPLA2). TaPLA2 was generated by homologous recombination of the recombinant vector pEGFP-N1-TaPLA2, induced by the CMV promoter, with . The structure of the protein was found to be typical of sPLA2, and it belongs to the phospholipase A2_3 superfamily. TaPLA2 enhanced antifungal drug resistance by upregulating the expression of effector genes and increasing the number of arthrospores to promote biofilm formation. TaPLA2 was highly sensitive to sodium dodecyl sulfate and Congo red, indicating impaired cell wall integrity due to downregulation of chitin synthesis or degradation genes, which can indirectly affect fungal resistance. In conclusion, overexpression enhanced the resistance to azoles of by enhancing drug efflux and biofilm formation and upregulating HOG-MAPK pathway genes; therefore, it has promising research prospects.

摘要

是一种机会致病菌,可导致免疫功能低下的患者发生严重甚至致命的感染。 在不同真菌中发挥不同作用,与真菌耐药性也有关。然而,在 中,其唑类药物耐药性的机制尚未报道。因此,我们通过构建过表达突变株(TaPLA2)来研究 ()的耐药性。TaPLA2 通过重组载体 pEGFP-N1-TaPLA2 与 的同源重组,由 CMV 启动子诱导产生。发现该蛋白的结构为典型的 sPLA2,属于磷脂酶 A2_3 超家族。TaPLA2 通过上调效应基因的表达和增加分生孢子的数量来促进生物膜形成,从而增强抗真菌药物的耐药性。TaPLA2 对十二烷基硫酸钠和刚果红高度敏感,表明由于几丁质合成或降解基因下调导致细胞壁完整性受损,这可能间接影响真菌耐药性。总之,过表达 TaPLA2 通过增强药物外排和生物膜形成以及上调 HOG-MAPK 通路基因来增强对唑类药物的耐药性;因此,它具有广阔的研究前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/3baee5f9d61e/ijms-24-08855-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/9733feb7c6f0/ijms-24-08855-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/1c7b60d875fd/ijms-24-08855-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/8afbbc91ac3b/ijms-24-08855-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/3d0ee15f746c/ijms-24-08855-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/d150dbcadba9/ijms-24-08855-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/584d1732b794/ijms-24-08855-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/57b13789c561/ijms-24-08855-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/84a8b5f33c0a/ijms-24-08855-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/546e54281a70/ijms-24-08855-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/3baee5f9d61e/ijms-24-08855-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/9733feb7c6f0/ijms-24-08855-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/1c7b60d875fd/ijms-24-08855-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/8afbbc91ac3b/ijms-24-08855-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/3d0ee15f746c/ijms-24-08855-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/d150dbcadba9/ijms-24-08855-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/584d1732b794/ijms-24-08855-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/57b13789c561/ijms-24-08855-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/84a8b5f33c0a/ijms-24-08855-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/546e54281a70/ijms-24-08855-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d5d/10219205/3baee5f9d61e/ijms-24-08855-g010.jpg

相似文献

1
Gene Enhances Drug Resistance to Azoles by Improving Drug Efflux and Biofilm Formation.基因通过提高药物外排和生物膜形成来增强对唑类药物的耐药性。
Int J Mol Sci. 2023 May 16;24(10):8855. doi: 10.3390/ijms24108855.
2
A New Amino Acid Substitution at G150S in Lanosterol 14-α Demethylase (Erg11 protein) in Multi-azole-resistant Trichosporon asahii.多唑耐药性白吉利毛孢子菌中羊毛甾醇14-α去甲基酶(Erg11蛋白)G150S位点的新氨基酸替换
Med Mycol J. 2017;58(1):E23-E28. doi: 10.3314/mmj.16-00027.
3
Analysis among Clinical Isolates of Trichosporon asahii with Different Azole Susceptibility Profiles.不同唑类药物敏感性表型曲霉菌属临床分离株的分析。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0110122. doi: 10.1128/aac.01101-22. Epub 2022 Nov 14.
4
Cloning of the lanosterol 14-α-demethylase ( ERG11 ) gene in Trichosporon asahii: a possible association between G453R amino acid substitution and azole resistance in T. asahii.在 Aspergillus terreus 中克隆角鲨烯 14-α-脱甲基酶( ERG11 )基因:可能与 T. asahii 中 G453R 氨基酸取代和唑类药物耐药性有关。
FEMS Yeast Res. 2012 Sep;12(6):662-7. doi: 10.1111/j.1567-1364.2012.00816.x. Epub 2012 Jun 18.
5
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.新兴真菌病原体阿萨希毛孢子菌的生物膜形成:发育、结构及抗真菌耐药性
Antimicrob Agents Chemother. 2006 Oct;50(10):3269-76. doi: 10.1128/AAC.00556-06.
6
Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients.从墨西哥患者中分离出的阿萨希毛孢子菌的生物膜形成及抗真菌药敏性
Rev Iberoam Micol. 2018 Jan-Mar;35(1):22-26. doi: 10.1016/j.riam.2017.02.008. Epub 2017 Dec 26.
7
Exploring the resistance mechanisms in Trichosporon asahii: Triazoles as the last defense for invasive trichosporonosis.探索新型隐球菌的耐药机制:唑类药物作为侵袭性新型隐球菌病的最后防线。
Fungal Genet Biol. 2019 Dec;133:103267. doi: 10.1016/j.fgb.2019.103267. Epub 2019 Sep 9.
8
[Antifungal susceptibility and drug-resistant mechanism of Trichosporon].[丝孢酵母的抗真菌药敏性及耐药机制]
Med Mycol J. 2015;56(4):J123-8. doi: 10.3314/mmj.56.J123.
9
Genomic and transcriptome identification of fluconazole-resistant genes for Trichosporon asahii.曲霉菌属对氟康唑耐药基因的基因组和转录组鉴定。
Med Mycol. 2020 Apr 1;58(3):393-400. doi: 10.1093/mmy/myz088.
10
Implication of efflux pumps and genes in resistance of clinical isolates to fluconazole.外排泵和基因对临床分离株对氟康唑耐药性的影响。
J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001236. Epub 2021 Mar 10.

引用本文的文献

1
Trichosporon and Antifungal Resistance: Current Knowledge and Gaps.毛孢子菌与抗真菌耐药性:当前认知与差距
Mycopathologia. 2025 Jul 4;190(4):59. doi: 10.1007/s11046-025-00969-z.
2
Characterization of Virulence Factors, Cellular Stress Response, and Antifungal Susceptibility Testing of spp. Isolated from Northeast Brazilian Patients.从巴西东北部患者分离出的 spp. 的毒力因子表征、细胞应激反应及抗真菌药敏试验
J Fungi (Basel). 2025 Mar 26;11(4):255. doi: 10.3390/jof11040255.
3
Identification of the ADH gene family in Trichosporon asahii and the role of TaADH_like in pathogenicity and fluconazole resistance.

本文引用的文献

1
Pathogenicity of phospholipase B1 of Trichosporon asahii in immunosuppressed mice.近平滑假丝酵母磷脂酶 B1 在免疫抑制小鼠中的致病性。
Mycoses. 2023 Jun;66(6):467-476. doi: 10.1111/myc.13568. Epub 2023 Mar 15.
2
A secretory phospholipase A2 of a fungal pathogen contributes to lipid droplet homeostasis, assimilation of insect-derived lipids, and repression of host immune responses.一种真菌病原体的分泌型磷脂酶A2有助于脂滴稳态、昆虫来源脂质的同化以及宿主免疫反应的抑制。
Insect Sci. 2022 Dec;29(6):1685-1702. doi: 10.1111/1744-7917.13029. Epub 2022 Apr 5.
3
Function of the phosphatidylinositol synthase Pis1 in maintenance of endoplasmic reticulum function and pathogenicity in Candida albicans.
嗜皮假丝酵母中ADH基因家族的鉴定以及TaADH_like在致病性和氟康唑耐药性中的作用
BMC Genomics. 2025 Apr 7;26(1):352. doi: 10.1186/s12864-025-11546-5.
4
: emerging challenges in pathogenesis and drug resistance.发病机制和耐药性方面的新挑战
Future Microbiol. 2025 Mar;20(4):333-343. doi: 10.1080/17460913.2025.2457858. Epub 2025 Jan 27.
5
Unveiling the nanoworld of antimicrobial resistance: integrating nature and nanotechnology.揭开抗微生物耐药性的纳米世界:融合自然与纳米技术
Front Microbiol. 2025 Jan 9;15:1391345. doi: 10.3389/fmicb.2024.1391345. eCollection 2024.
6
Comparative Study and Transcriptomic Analysis on the Antifungal Mechanism of Ag Nanoparticles and Nanowires Against .Ag 纳米颗粒和纳米线抗. 的抗真菌机制比较研究及转录组学分析
Int J Nanomedicine. 2024 Nov 13;19:11789-11804. doi: 10.2147/IJN.S474299. eCollection 2024.
磷脂酰肌醇合成酶Pis1在白色念珠菌内质网功能维持及致病性中的作用
Fungal Genet Biol. 2022 May;160:103674. doi: 10.1016/j.fgb.2022.103674. Epub 2022 Feb 26.
4
Enhancing the Biocontrol Potential of the Entomopathogenic Fungus in Multiple Respects via the Overexpression of a Transcription Factor Gene .通过转录因子基因的过表达在多个方面增强昆虫病原真菌的生防潜力
J Fungi (Basel). 2022 Jan 21;8(2):105. doi: 10.3390/jof8020105.
5
Secreted Phospholipases A - not just Enzymes: Revisited.分泌型磷脂酶 A2——不只是酶:再探。
Int J Biol Sci. 2022 Jan 1;18(2):873-888. doi: 10.7150/ijbs.68093. eCollection 2022.
6
Phospholipase A, a nonnegligible enzyme superfamily in gastrointestinal diseases.磷脂酶 A,胃肠道疾病中不可忽视的酶超家族。
Biochimie. 2022 Mar;194:79-95. doi: 10.1016/j.biochi.2021.12.014. Epub 2021 Dec 30.
7
Inhibitory effect of polyunsaturated fatty acids alone or in combination with fluconazole on Candida krusei biofilms in vitro and in Caenorhabditis elegans.多不饱和脂肪酸单独或与氟康唑联合对体外克柔念珠菌生物膜及秀丽隐杆线虫的抑制作用。
Med Mycol. 2021 Dec 3;59(12):1225-1237. doi: 10.1093/mmy/myab055.
8
Development of an efficient gene-targeting system for elucidating infection mechanisms of the fungal pathogen Trichosporon asahii.开发一种高效的基因靶向系统,以阐明真菌病原体近平滑念珠菌的感染机制。
Sci Rep. 2021 Sep 14;11(1):18270. doi: 10.1038/s41598-021-97287-3.
9
Azole resistance mechanisms in pathogenic .致病性真菌中的唑类耐药机制
Antimicrob Agents Chemother. 2021 May 1;65(5). doi: 10.1128/AAC.01975-20. Epub 2021 Feb 22.
10
A Overexpression Collection Reveals Genes Required for Pathogenesis.A过表达文库揭示了致病所需的基因。
J Fungi (Basel). 2021 Jan 29;7(2):97. doi: 10.3390/jof7020097.